The method to the dengue virus's maddening infectiousness.
The Scientist
Most Recent
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Contrary to previous assumptions that macrolide antibiotics completely block the exit tunnel of ribosomes, new evidence shows that some peptides are allowed to pass.
An Oregon teenager spent a summer in a New York biochemistry lab helping to discover a novel molecule that could become the next commercial nonaddictive painkiller.
The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
